en · de · es · fr · pt
ipamorelin-notes.peptides6823.com › Topic › Receptor Selectivity And Secretagogue Signaling — Reference Sheet

Receptor Selectivity And Secretagogue Signaling — Reference Sheet

By Editorial Desk · published 2025-10-10 · last reviewed 2025-11-30 · Topic

A practical reference on pentapeptide: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

Reviewed 2025-11-30. Anything still debated is marked as such rather than presented as settled.

Receptor Selectivity and Secretagogue Signaling

Structural features distinguish the molecule from earlier secretagogues. An alpha-aminoisobutyric acid residue near the N-terminus and a D-naphthylalanine substitution increase receptor affinity, while C-terminal amidation improves resistance to exopeptidases. These modifications are associated with reduced stimulation of appetite and of the hypothalamic-pituitary-adrenal axis compared with hexarelin or growth hormone releasing peptide-6. Whether the same profile applies at every dose level studied is a matter of ongoing investigation rather than settled consensus.

Ipamorelin is a synthetic pentapeptide that acts as an agonist at the ghrelin receptor, also called the growth hormone secretagogue receptor type 1a. Its sequence incorporates non-natural residues, which slows enzymatic breakdown relative to short native peptides. In laboratory and early clinical work the compound is described as a selective growth hormone secretagogue because it raises growth hormone with comparatively little effect on other pituitary outputs. The degree to which that selectivity holds across species and dosing regimens remains an open question in the published literature.

Signal transduction begins when the peptide binds GHSR-1a on pituitary somatotrophs. The receptor couples to Gq/11 proteins, activating phospholipase C, which cleaves phosphatidylinositol bisphosphate into inositol trisphosphate and diacylglycerol. Inositol trisphosphate releases calcium from intracellular stores, and the resulting rise in cytosolic calcium drives growth hormone vesicle fusion. Concurrent Gs coupling and cyclic AMP elevation have also been reported, and the relative contribution of each arm to the overall secretory response is not fully settled.

背景与分子特征

从用途定位看,ipamorelin 目前主要以研究用肽的身份被讨论,未见主要药品监管机构将其批准为治疗药物。市售材料通常标注仅供研究使用,不得用于人体或诊断程序。文献中它常与生长激素促分泌素、GHS-R1a 激动剂、胃饥饿素拟似物等表述并列出现。既有研究的样本量普遍偏小,因此对其效应强度与一致性的描述应保持谨慎。

Ipamorelin 是一种合成五肽,序列为 Aib-His-D-2-Nal-D-Phe-Lys-NH2,分子式 C38H49N9O5,游离碱分子量约 711.85 g/mol。它属于生长激素促分泌素(GHS)家族,作用靶点是胃饥饿素受体 GHS-R1a。该化合物由诺和诺德的研究团队在二十世纪九十年代末报道,设计目标是提高对生长激素释放的选择性。C 端酰胺化与 N 端 Aib 残基是两个用于抵抗肽酶降解的结构特征。

Ipamorelin at a glance

PropertyValueNotes
Molecular formulaC38H49N9O5Reported for the free peptide
Molecular mass711.85 DaMonoisotopic value
Residue motifAib-His-D-2-Nal-D-Phe-Lys-NH2Non-natural residues at positions one and three
Primary targetGHSR-1aGhrelin receptor, G protein coupled
Reported plasma half-lifeAbout two hoursValues vary with assay and subject group

Ipamorelin Background and Receptor Selectivity

At the molecular level, ipamorelin acts as an agonist at the growth hormone secretagogue receptor type 1a, the same G protein-coupled receptor that binds ghrelin. Receptor activation couples to Gq/11 signaling, raising intracellular calcium through inositol trisphosphate and diacylglycerol, which in turn promotes exocytosis of growth hormone from pituitary somatotroph cells. Ipamorelin binds this receptor with high affinity and shows weak activity at other secretagogue-related targets in vitro. Its action requires the intact receptor and is not reversed by growth hormone-releasing hormone antagonists.

Compared with earlier growth hormone secretagogues such as GHRP-6 and hexarelin, ipamorelin has been reported to produce less stimulation of adrenocorticotropic hormone, cortisol, and prolactin in animal and early human studies. This selectivity is usually attributed to differences in receptor subtype interactions and to the tissue distribution of the receptor. Effects on appetite appear weaker than those of ghrelin itself, although the supporting evidence base is small. Whether these differences produce a distinct clinical profile remains an open question, since controlled human trials are limited.

Ipamorelin is a synthetic pentapeptide first described in the 1990s by researchers at Novo Nordisk during a program to develop selective growth hormone secretagogues. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, incorporating two non-natural residues, alpha-aminoisobutyric acid and D-2-naphthylalanine. The C-terminus is amidated, and the material is supplied as a white lyophilized powder. The molecular formula is C38H49N9O5 and the monoisotopic mass is approximately 711.85 daltons. The short chain and modified residues give it greater resistance to enzymatic degradation than many larger peptide hormones.

Related pages on this site

Background And Receptor Mechanism

Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue family. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, and its molecular mass is approximately 711.9 daltons. The compound was described in the late 1990s by researchers seeking molecules that release growth hormone with fewer side effects than earlier secretagogues. It is a laboratory and research compound, not an approved medicine in most jurisdictions.

At the molecular level, ipamorelin acts as an agonist at the growth hormone secretagogue receptor, also called the ghrelin receptor or GHS-R1a. Binding to this receptor on pituitary somatotroph cells triggers a signaling cascade that leads to growth hormone release. The effect is mediated through phospholipase C and calcium mobilization rather than through the cyclic AMP pathway used by growth hormone releasing hormone. The two pathways are complementary, and combined stimulation produces a larger response than either alone.

Background from the literature

In June 1789, the regiment was formed in England as a permanent unit to relieve the New South Wales Marine Corps, who had accompanied the First Fleet to Australia. The regiment began arriving as guards on the Second Fleet in 1790. The regiment, led by Major Francis Grose, consisted of three companies, numbering about 300 men. Although drafts were sent from Britain to reinforce the regiment throughout its time in Australia, its full strength never exceeded 500. A fourth company was raised from those Marines wishing to remain in New South Wales under Captain George Johnston, who had been Governor Arthur Phillip's aide-de-camp. In December 1792, when Phillip returned to England for respite, Grose was left in charge. Grose immediately abandoned Phillip's plans for governing the colony. A staunch military man, he established military rule and set out to secure the authority of the Corps. He abolished the civilian courts and transferred the magistrates to the authority of Captain Joseph Foveaux. After the poor crops of 1793 he cut the rations of the convicts but not those of the Corps, overturning Phillip's policy of equal rations for all. In a connived attempt to improve agricultural production and make the colony more self-sufficient, Grose turned away from collective farming and made generous land grants to officers of the Corps. They were also provided with government-fed and clothed convicts as farm labour.

Alcohol dehydrogenase class-3 is an enzyme that in humans is encoded by the ADH5 gene. This gene encodes glutathione-dependent formaldehyde dehydrogenase or the class III alcohol dehydrogenase chi subunit, which is a member of the alcohol dehydrogenase family. Members of this family metabolize a wide variety of substrates, including ethanol, retinol, other aliphatic alcohols, hydroxysteroids, and lipid peroxidation products. Class III alcohol dehydrogenase is a homodimer composed of 2 chi subunits. It has virtually no activity for ethanol oxidation, but exhibits high activity for oxidation of long-chain primary alcohols and for oxidation of S-hydroxymethyl-glutathione, a spontaneous adduct between formaldehyde and glutathione. This enzyme is an important component of cellular metabolism for the elimination of formaldehyde, a potent irritant and sensitizing agent that causes lacrymation, rhinitis, pharyngitis, and contact dermatitis.

A transdermal patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. An advantage of a transdermal drug delivery route over other types of medication delivery (such as oral, topical, intravenous, or intramuscular) is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive. The main disadvantage to transdermal delivery systems stems from the fact that the skin is a very effective barrier; as a result, only medications whose molecules are small enough to penetrate the skin can be delivered by this method. The first commercially available prescription patch was approved by the U.S. Food and Drug Administration in December 1979. These patches administered scopolamine for motion sickness. In order to overcome restriction from the skin, researchers have developed microneedle transdermal patches (MNPs), which consist of an array of microneedles, which allows a more versatile range of compounds or molecules to be passed through the skin without having to micronize the medication beforehand. MNPs offer the advantage of controlled release of medication and simple application without medical professional assistance required. With advanced MNPs technology, drug delivery can be specified for local usage, for example skin whitener MNPs that are applied to the face.

=== Bombing test === This method applies to objects that are supposedly hermetically sealed such as implantable medical devices, crystal oscillator, saw filter devices, transistors, microprocessors, etc. First the device under test will be exposed to helium pressure (typically 30-60psi) in a "bombing" chamber for an extended time period. If the part is leaky, helium will be able to penetrate the device. Later the device will be placed in a vacuum chamber, connected to a vacuum pump and a mass spectrometer. The tiny amount of gas that entered the device under pressure will be released in the vacuum chamber and sent to the mass spectrometer where the leak rate will be measured down to 10−9 mbar·L·s−1. This method is not able to detect a massive leak as the tracer gas will be quickly pumped out when test chamber is pumped down.

Comfort temperature is interchangeable with neutral temperature in the scientific literature, which can be calculated through regression analysis between thermal sensation votes and indoor temperature. The neutral temperature is the solution of the resulting regression model by setting the thermal sensation vote as zero. The American Heritage Dictionary of the English Language identifies room temperature as around 20–22 °C (68–72 °F; 293–295 K), while the Oxford English Dictionary states that it is "conventionally taken as about 20 °C (68 °F; 293 K)". Ideal room temperature varies vastly depending on the surrounding climate . Studies from Indonesia have shown that the range of comfortable temperature is 24–29 °C (75–84 °F) for local residents. Studies from Nigeria show a comfortable temperature range of 26–28 °C (79–82 °F), comfortably cool 24–26 °C (75–79 °F) and comfortably warm 28–30 °C (82–86 °F). A field study conducted in Hyderabad, India returned a comfort band of 26–32.45 °C (79–90 °F) with a mean of 29.23 °C (85 °F). A study conducted in Jaipur, India among healthy young men showed that the neutral thermal comfort temperature was analyzed to be 30.15 °C (86 °F), although a range of 25.9–33.8 °C (79–93 °F) was found. People are highly sensitive to even small differences in environmental temperature. At 24 °C (75 °F), a difference of 0.38 °C (0.68 °F) can be detected between the temperature of two rooms.

Sources: en.wikipedia.org

Further detail

India, officially the Republic of India, is a country in South Asia. It is the world's seventh-largest country by area and its most populous. Bounded by the Indian Ocean on the south, the Arabian Sea on the southwest, and the Bay of Bengal on the southeast, it shares land borders with Pakistan to the west, China, Nepal, and Bhutan to the north, and Bangladesh and Myanmar to the east. In the Indian Ocean, India is near Sri Lanka and the Maldives. Modern humans arrived on the Indian subcontinent from Africa by 55,000 years ago. Settled life emerged in the western margins of the Indus river basin 9,000 years ago, evolving into the Indus Valley Civilisation of the third millennium BCE. By 1200 BCE, an archaic form of Sanskrit, an Indo-European language, diffused into India from the northwest, its earliest hymns containing elements of what would become Hinduism. The pre-existing Dravidian and other languages were gradually superseded in India's northern plains. Across the central stretch of these plains, rapid urbanisation took place, and after 500 BCE a caste-based, hereditary form of social stratification began to solidify as Hinduism took fuller shape. During this period, Buddhism and Jainism arose, proclaiming social orders unlinked to heredity. The subsequent emergence of the loose-knit Maurya and Gupta Empires gave rise to wide-ranging cultural and scientific creativity. However, these eras saw a steady decline in women's status, alongside the eventual institutionalisation of untouchability.

==== Biotextile scaffolds for tissue regeneration ==== The development of a collagen biotextile scaffold for aiding in the healing process of large deep burn wounds has been achieved by researchers at UC Davis. This scaffold, utilizing a specially engineered biomaterial, has demonstrated efficacy in promoting the formation of new blood vessels and reducing complications associated with severe burns. The study highlights the scaffold's ability to accelerate wound healing in mouse models and mitigate burn-related complications such as fluid loss and infection. Through testing different scaffold types, the research team observed that the combined treatment loaded with endothelial cells exhibited the highest wound healing rate.

== See also == Indian Institute of Remote Sensing Intel Research Lablets Remote sensing in mobile telecommunications NODE platform Quality control system (QCS) for web and papers SWARM Wireless sensor network nodes

Among other receptors represented by gangliosides GT1b is highly expressed on the outer membranes of brain metastases cells that originate from an extremely broad range of cancer, while GD1a, GT1b and GQ1b can be detected in human gliosarcomas. However, their quantity is not exceeding the quantity in normal frontal cerebral cortex. The asialoglycoprotein receptors that bind Sendai virus. and serve as SeV cell entry receptors are highly expressed in liver cancers.

Sources: en.wikipedia.org

Frequently asked questions

How does ipamorelin relate to ghrelin?

Both molecules activate the same receptor, GHSR-1a, but they share little sequence identity. Ghrelin is a 28-amino-acid hormone carrying a distinctive acyl modification, whereas ipamorelin is a short synthetic peptide. The shared target explains overlapping endocrine effects, while the different structures account for differences in metabolic stability and receptor selectivity.

Why is it described as selective?

Early animal and human studies reported growth hormone release at levels that produced small changes in cortisol, prolactin and adrenocorticotropic hormone. That contrast with older secretagogues gave rise to the selectivity label. The observation is consistent across several reports but rests on a limited number of small studies.

What is known about its metabolism?

Plasma peptidases cleave the molecule into smaller fragments, and reported half-lives in human studies are on the order of a couple of hours. The identity and activity of individual breakdown products have not been fully mapped. Questions about tissue-level clearance remain open.

Ipamorelin 与 GHRP-6 有什么不同?

两者都是 GHS-R1a 激动剂,但 ipamorelin 在研究中显示出更高的生长激素释放选择性。早期资料显示它对皮质醇、催乳素与食欲的刺激弱于 GHRP-6。这些差异是相对程度,而非绝对区分。

Network